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Abstract: The purpose of this study was to evaluate central and parafoveal inner retinal layer thick-
ness in patients with subretinal drusenoid deposits (SDD) or conventional drusen (CD). Participants
underwent comprehensive ophthalmoscopic examination. Evidence of SDD or CD was evaluated
with near infrared reflectance and spectral domain optical coherence tomography. Quantification
of subfoveal lesions was made through a qualitative analysis of vertical and horizontal SD-OCT
scans centered on the fovea. Inner retinal layer macular thickness measurements were obtained for
central circles with 1, 3, and 5 mm diameter. Continuous variables were compared by the analysis
of covariance (ANCOVA) with post-hoc Tukey HSD correction for multiple comparison analysis.
Fifty-five patients were included in the study; 18 eyes with SDD alone, 19 eyes with CD alone, and
18 eyes of healthy age-matched subjects. Eight eyes with SDD (44%) and 13 eyes with CD (68%)
had subfoveal lesions. There was significant reduction in the inner retinal layer thickness in the
central 1mm area and in the superior 3 mm area in the SDD and CD group compared to controls.
In conclusion the inner retinal layer is thinner in the central macula and in the superior parafovea
in eyes.
Keywords: subretinal drusenoid deposits; reticular pseudodrusen; conventional drusen; age related
macular degeneration; inner retina
1. Introduction
Late manifestations of age related macular degeneration (AMD) are the primary
pathology responsible for irreversible loss of vision in developed countries. The principal
hallmarks of AMD are drusen that are focal deposits of extracellular material beneath
the retinal pigment epithelium [1]. Growing evidence shows that subretinal drusenoid
deposits (SDD), otherwise called reticular pseudodrusen, are an important phenotype in
AMD. These deposits are located in the subretinal space, between the photoreceptors and
retinal pigment epithelium layer with different retinal topography with respect to drusen
as they are localized predominantly in the superior macula outside of the fovea, and to
a less extent in the foveal region, whereas soft drusen are characteristically found in the
central macula [2,3]. Classically AMD is characterized by outer retinal involvement [4,5]
however, recent evidence has also shown inner retinal layer changes [6–8]. Thinning of the
inner retinal structures has been reported for the retinal nerve fiber layer (RNFL), ganglion
cell layer (GCL), inner plexiform layer (IPL), and ganglion cell complex (GCC) [9–12].
Suggested pathogenetic theories for inner retinal involvement are microvascular alterations
with inner retinal ischemia and post-receptor trans-synaptic degeneration [1,6,7,11,13,14].
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SDD are associated with both forms of late AMD, geographic atrophy and neovasculariza-
tion [15]. In eyes with SDD there is substantial literature on the outer retinal layers and
the choroid [16–18]. Only two reports describe the inner retinal changes in eyes with SDD
where thinning of the GCL and IPL was shown [19,20]. Although conventional drusen (CD)
and SDD are frequently found simultaneously in eyes with AMD [21,22] with a prevalence
of one or the other, the ideal model of study would be to stratify and separately analyze
eyes with either one or the other type of deposits alone. Therefore, in the present report we
used strict inclusion and exclusion criteria to select patients and assess inner layer thickness
in the central and parafoveal macular area among eyes with pure SDD, pure CD, and eyes
of healthy age-matched subjects.
2. Materials and Methods
This was an observational cross-sectional study including 55 eyes of 55 subjects
(18 eyes with SDD, 19 eyes with CD, and 18 eyes of healthy age-matched subjects) carried
out at the Retina Centre of the Ophthalmology Unit of the University of Rome Sapienza, St.
Andrea Hospital. The study had Institutional Review Board Approval from the University
of Rome, Sapienza. All the procedures were performed in agreement with the principles of
the declaration of Helsinki. Informed consent was obtained from the subjects after explana-
tion of the nature of the study. Inclusion criteria were diagnosis of early/intermediate AMD
in patients with age above 50 years and near infrared reflectance (NIR) and spectral domain
optical coherence tomography (SDOCT) evidence of CD (defined as the CD group) or SDD
(defined as the SDD group). Healthy age-matched subjects were included as the control
group and were patients who underwent routine ophthalmological examination in our gen-
eral ophthalmology clinic. Exclusion criteria were spherical equivalent above 4 Diopters;
glaucoma or intraocular pressure above 18 mmHg or altered disk aspect such as notching,
hemorrhage, thinning of the neuroretinal rim, cup to-disk ratio difference of more than 0.2
between fellow eyes and optic atrophy; diabetic retinopathy; hypertensive retinopathy;
SDOCT evidence of epiretinal membranes; presence of neurological disease; and fundus
autofluorescence evidence of the presence of retinal pigment epithelium (RPE) atrophy or
vitelliform deposits. Each patient underwent comprehensive ophthalmoscopic examination
including assessment of best corrected visual acuity (BCVA) and refractive error, slit lamp
evaluation of the anterior segment, tonometry, and fundus examination. Photographic
documentation of the posterior pole was performed using the photographic setting of
the compass perimeter (Centervue). The evidence of SDD or CD was evaluated by two
operators through the simultaneous evaluation of NIR images (Heidelberg HRT II) com-
pared with raster images on SDOCT (Rtvue XR Avanti, Optovue, Inc, Fremont, CA, USA)
according to the classification system proposed by Zweifel et al. and Spaide et al. [2,23].
Patients in the SDD group had to have evidence of at least 5 subretinal drusenoid deposits
in the diameter of a papillary disc area. The presence of any CD equal to or larger than
63 µm was a reason for exclusion. Patients in the CD group had to have at least one drusen
larger than 125 µm or 5 drusen between 63 and 125 µm. In order to better characterize the
eyes under investigation, a quantification of the subfoveal lesions present in the two groups
was made through a qualitative analysis of vertical and horizontal SDOCT scans centered
on the fovea. In the SDD group 8 eyes out of 18 had subfoveal lesions (44%), while in the
CD group 13 eyes out of 19 had subfoveal lesions (68%) (Figure 1). SDOCT evaluation in
all patients and subjects was carried out with the following scan protocols: raster with
17 parallel-lines of standard length and width; grid with 5 vertical and 5 horizontal lines
centered on the fovea; and retina map with thickness output organized in 9 Early Treatment
Diabetic Retinopathy Study (ETDRS) zones, formed by circles of 1 mm, 3 mm, and 5 mm
diameter centered on the fovea as defined by Gass [24]. Automated segmentation of the
inner retina was carried out using Optovue software 2017.1.0.151 from the inner limiting
membrane to the outer border of the IPL. Thickness values were recorded in the 9 central
zones where the 3mm and 5mm diameter areas were further divided into superior, nasal,
temporal, and inferior sectors [24]. Scans with quality inferior to 5/10 were rejected and
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re-acquired. Two expert investigators (MDP, ES) evaluated automated segmentation to
check for any misalignment and in case of doubt, a senior investigator (SA) was consulted.
No cases of misalignment were observed. In bilateral AMD, the choice of the eye included
for analysis in the SDD and CD group was based on exclusion criteria; in the SDD and CD
groups 12 and 9 fellow eyes had exclusion criteria, respectively. When both eyes in the
SDD, CD, and healthy control groups could potentially be included, according to the inclu-
sion/exclusion criteria, we used a random number generator where odd numbers were
for right eyes and even numbers for left eyes. Data were expressed as mean ± standard
deviation or median and interquartile range for continuous variables, and the number of
cases (and percentages) for categorical variables. All variables were tested for normality
using the non-parametric Kolmogorov-Smirnov test. Continuous variables were compared
by the analysis of covariance (ANCOVA), adjusted for age, and a post-hoc Tukey HSD
correction analysis was performed for multiple comparison analysis. Differences between
means of SDD and CD group were tested using t-test with Bonferroni correction when
required. Categorical variables were evaluated using the χ-square test or Fisher exact test
when appropriate. A p value ≤ 0.05 was considered statistically significant.
χ ≤
 
Figure 1. Spectral domain optical coherence tomography (SDOCT) scan of an eye with subfoveal
subretinal drusenoid deposits (SDD). The SDOCT cross-sectional scan shows hyperreflective material
between the retinal pigment epithelium and the ellipsoid zone with focal changes of the latter. SDD
located under the fovea is shown with the arrow.
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3. Results
The sample included 18 eyes with SDD (SDD group), 19 eyes with CD (CD group), and
18 eyes of healthy age-matched subjects (control group). The mean age of the SDD group
was 79.39 ± 8.06, the mean age of the CD group was 80.53 ± 5.35, and the mean age of the
control group was 75.61 ± 6.89 years. The ages in these three groups were homogeneous
and did not show statistically significant differences (p = 0.842). No difference in gender,
BCVA, and spherical equivalent between groups was found. Demographic data are shown
in Table 1.






p-Value a Control Group (n = 18) p-Value b
Age (Years) 79.39 ± 8.06 80.53 ± 5.35 0.614 c 75.61 ± 6.89 0.842 e
Sex (M/F) 13/5 9/10 0.183 d 7/11 0.113 d
BCVA (logMAR) 0.85 ± 0.19 0.86 ± 0,17 0.868 c 0.92 ± 0.11 0.331 e
Spherical Equivalent (Diopters) 0.11 ± 1.40 −0.13 ± 0.89 0.533 c 0.04 ± 0.1 0.780 e
Phakic/Pseudophakic 13/5 12/7 0.721 d 12/6 0.840 d
BCVA: best-corrected visual acuity, LogMAR: logarithm of the minimal angle of resolution. a: Comparison of eyes with SDD versus eyes
with CD. b: Comparison of eyes with SDD, eyes with CD and control group eyes (control group). c: T-test with Bonferroni correction.
d: Fisher’s exact test. e: ANOVA.
Each group included patients with SDD only or CD only, assessed by NIR examination
and SDOCT scans. Covariance analysis showed a significant reduction (p ≤ 0.05) in the
macular inner layer thickness in the central 1 mm area in the SDD group (70 ± 6.10 µm)
and in the CD group (69.21± 9.72 µm) compared to controls (78.22 ± 11.31 µm) (Figure 2);
while no difference was detected between the SDD and CD group. A significant reduction
of inner retinal thickness was detected in the superior sector within 3 mm above the fovea,
in the SDD group and in the CD group compared to controls (p = 0.003) (Figure 3). No
other statistically significant differences were found in the analysis in the inferior, temporal,
and nasal areas at 3 mm and in the superior, inferior, temporal, and nasal areas at 5 mm
between the SDD and CD groups, and between these groups with respect to controls.
In order to assess the direct influence of the presence of SDD or CD on the inner retinal
thickness, a separate comparison between the SDD group and control group and between
the CD group and control group was also performed. Inner retinal thickness in the SDD
group compared to the control group was significantly reduced in the central 1 mm circle
area (p = 0.026) and in the superior sector of the 3 mm area (p = 0.002). Similar results
emerged in the comparison analysis between the CD group and control group. All results
are summarized in Table 2.











Figure 2. Box-plots of inner retina thickness in the central 1 mm diameter in SDD group, CD group and controls. The






Figure 3. Box-plots of inner retina thickness in the superior 3 mm diameter in SDD group, CD group and controls. The
superior 3mm inner retina thickness in healthy eyes is greater than in eyes with SDD or CD. The whiskers represent the
lower and upper quartile.
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Table 2. Analysis of inner retinal thickness in eyes with subretinal drusenoid deposits (SDD), conventional drusen (CD),







Group (n = 18)
p-Value b p-Value e p-Value f
Central 1mm 70 ± 6.10 69.21 ± 9.72 0.964 c 78.22 ± 11.31 0.004 d* 0.026 c* 0.013 c*
Superior 3 mm 118.83 ± 8.99 119.89 ± 9.97 0.935 c 129.55 ± 8.58 0.003 d* 0.002 c* 0.007 c*
Inferior 3 mm 119.88 ± 10.49 117.52 ± 13.92 0.814 c 123.11 ± 10.07 0.747 d 0.683 c 0.324 c
Temporal 3 mm 114.72 ± 9.62 114.26 ± 11.77 0.448 c 119.50 ± 10.45 0.472 d 0.372 c 0.306 c
Nasal 3 mm 117.44 ± 8.44 118 ± 10.10 0.986 c 124.44 ± 12.69 0.178 d 0.120 c 0.164 c
Superior 5 mm 101.61 ± 10.12 103.21 ± 8.46 0.854 c 106.88 ± 8.49 0.400 d 0.191 c* 0.441 c
Inferior 5 mm 100 ± 6.12 98.47 ± 10.69 0.860 c 102.16 ± 8.89 0.814 d 0.738 c 0.419 c
Temporal 5 mm 99.88 ± 10.74 99.52 ± 12.71 0.994 c 105.33 ± 10.73 0.572 d 0.329 c 0.283 c
Nasal 5 mm 105.66 ± 10.92 110.57 ± 11.33 0.460 c 112.38 ± 14.69 0.306 d 0.238 c 0.898 c
a: Comparison of eyes with SDD a Comparison of eyes with SDD versus eyes with CD. b: Comparison of eyes with SDD, eyes with CD,
and control group eyes (control group). c: Post hoc Tukey Honest Significant Difference (HSD), multiple comparison between groups.
d: Analysis of Covariance (ANCOVA), adjusted for age. e: Comparison of eyes with SDD and control group eyes (control group). f:
Comparison of eyes with CD and control group eyes (control group). * Statistically significant (p < 0.05).
4. Discussion
The current study showed that the inner retina was thinner in the central macula and
superior parafoveal area in early/intermediate AMD in eyes with SDD or conventional
drusen with respect to age-matched control eyes.
AMD is a progressive disease that has traditionally been regarded as an outer retinal
disorder [4,5]. However, some authors evaluated inner retinal thickness by measuring the
RNFL, GCL, IPL, and GCC and showed thinning of the inner retina [5–8,10,25]. In these
studies topographical macular areas of evaluation, SDOCT instruments, the specific layers
studied, and the classification of early or intermediate AMD were not uniform and varied
widely, direct comparisons are therefore limited [5–8,10,25]. In large measure our results
are consistent with these reports as we demonstrated that the inner retina is thinner in
early stages of AMD.
In performing sectorial analysis we found thinning of the central and superior macular
areas in eyes with early AMD with respect to control eyes. The functional and structural
differences between the superior and inferior retina was reported by Curcio et al. who
showed histological evidence that the retinal ganglion cell and rod density in the superior
retina was higher than the inferior retina [26]. In in vivo studies, regional macular thickness
alterations have been linked to microvascular changes using OCTA [6,7,18]. Trinh et al.
reported a significant decrease in the superficial capillary plexus (SCP) retinal vessel density
of AMD eyes, particularly in the superior quadrant [6]. Ozcaliskan et al. found a decrease in
the parafoveal SCP density in eyes with intermediate AMD, in particular in the parafoveal
superior areas. These authors also correlated thickness measurements with vascular
density values and found that the mean parafoveal GCC was significantly correlated with
parafoveal SCP vessel density [7]. These results are in line with the present study where
we found thinning in the superior macular sectors. Lee et al. reported an annular pattern
of parafoveal thinning of the GCL-IPL [25], and in a previous publication we reported a
thinner GCL-IPL layer in the 3 and 6 mm EDTRS areas [20]. Hypotheses for this pattern
could be associated with the anatomical structure of the macula that physiologically thins
towards the fovea [27], the different topographic distribution of photoreceptors [7] or the
vascular supply characteristics of the foveal versus the parafoveal region [8,11].
Etiopathogenetic mechanisms proposed for inner retinal involvement in AMD have
been linked to trans-neural degeneration where post-receptorial functional loss due to
photoreceptor damage leads to synaptic impairment [6]; this would also involve the outer
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layer and outer nuclear thickness and possibly the amacrine and horizontal cells. Other
mechanisms include neurodegenerative disorders where inflammation and neuronal loss
are the main features [1]; and microvascular changes where chronic ischemia could cause
initial damage to the ganglion and inner plexiform layers cells [14], suggested even by
OCTA reports on alterations of the retinal microvascular plexus [6,7,28]. Furthermore,
ageing and systemic risk factors for AMD such as hypertension, atherosclerosis, and
smoking may also contribute to microvascular alterations of the retina [29–31].
While CD are commonly, prevalently localized in the central subfield, only few SDD
can be observed in this area. As described by Curcio et al. in histologic cases, SDD are
found preferentially in the perifoveal area, especially in the upper sector followed by the
nasal and temporal sectors, involving the foveal region in only 9% of cases [3]. For this
reason, the study of retinal thickness in the central 1 mm area in patients with SDD is
currently poorly evaluated, leaving room for a more in-depth study of the regions most
affected by their anatomical distribution. Recently Chiang et al. carried out a study of the
retinal macular thickness (including the central 1 mm area) in patients with SDD, patients
with various degrees of AMD, and a control group. Their study of the inner retina showed a
trend of retinal thickness reduction in the central 1mm area in patients with SDD compared
to controls [32]. Our study showed a reduction of the inner retina thickness in the central
1 mm area in patients with CD and in patients with SDD compared to controls. Thus, while
our finding of thinning of the inner retina in the 1 mm central subfield is plausible in the
CD group, it is rather surprising to find this in the SDD group as well. This result could
be explained by the particular characteristics of our sample where a careful analysis of
SDOCT scans showed a prevalence of 44% of foveal SDD. Another reason might be that
in excluding eyes with mixed drusen types and selecting eyes with pure SDD, these eyes
exhibit abundant drusenoid deposits including the 1mm foveal region. SDD distribution
has been reported to be preferentially in perifoveal areas where there is high rod density [3].
However, of note is that in the fovea the average horizontal diameter of the rod-free zone is
0.350 mm, whereas we evaluated a larger horizontal diameter of 1 mm in the foveal region
where rods can be found. We may speculate that the position of SDD in the foveal region
could “mimic” the behavior of CD resulting in a thinning of the central region, similar to
what happens in the parafoveal and perifoveal areas. It would be particularly interesting
to determine whether inner retinal layer thinning is dependent on the presence of foveal
1 mm area and superior 3 mm area lesions, however, in our study there was not enough
statistical power to stratify data.
In the present study there was no significant difference in inner retinal thickness
values between eyes in the CD and SDD groups. In a previous study we reported that eyes
associated with SDD had a significantly thinner GCL-IPL layer with respect to those with
CD alone [20]. However, the investigation compared eyes with CD alone to those with CD
associated with SDD, without a pure SDD group. Furthermore, the analysis in our previous
study was different from the present report where the inner retina analysis includes the
RNFL. To the best of our knowledge there is only one other study in the literature by
Cicinelli et al. where the authors found a thinner GCL in eyes with SDD compared to
those with CD [19]. However, Cicinelli et al. did not find any difference in RNFL values
and suggested that macular RNFL could be spared as they are the innermost nerve fibers
and are not initially involved in the process of trans-neuronal retrograde degeneration.
Moreover, compensatory proliferation of Müller and horizontal cells could also contribute
to maintaining RNFL thickness [33]. This could partially explain our results as in the
present paper inner retinal analysis included the RNFL. We could not directly compare
our data with the previous reports where RNFL and ganglion cell layer thickness were
evaluated with different SDOCT devices that enabled to measure these layers separately.
SDOCT Optovue software technology does not allow separate segmentation of the RNFL
and ganglion cell layer.
Our study had some limitations. Although, it would be interesting to evaluate thick-
ness measures for the outer nuclear layer in each of the three groups in order to possibly
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find correlative data for the restricted thinning of the inner retina, Optovue software tech-
nology limitations do not allow individual retinal layer thickness segmentation. Therefore,
our study design was specifically focused on inner retinal thickness alterations. The num-
ber of enrolled patients and subjects is small, however, the patients had pure SDD or CD,
whereas other studies also evaluated patients with mixed drusen types. The identification
of SDD was performed evaluating NIR images and structural SDOCT scans obtained
by two separate devices. The Rtvue XR Avanti Optovue device provides a map of the
thicknesses organized in ETDRS circles of 1, 3, and 5 mm diameter as defined by Gass [24]
centered on the fovea that are not the conventional 1, 3, and 6 mm circular areas studied by
other authors.
In conclusion our findings suggest that there is damage to the inner retinal layers in
early AMD based on structural thinning of the inner retina. Our study shows that the
presence of SDD causes thinning of the inner retinal layers in the superior parafovea and
the central 1mm area given the high prevalence of central SDD in our sample. Evaluation
of the difference in thickness between eyes with SDD and CD requires further study on
larger patient populations. An interesting line of research is the correlation of structural
thickness values with microvascular retinal alterations through OCTA as vascular involve-
ment in SDD is well known to involve the choroid that is thinner. Because vascularized
retinal layers correlate positively with choroidal thickness in normal eyes [31], a conjunct
evaluation of choroidal with retinal vascularity is reasonable to better understand disease
pathophysiology and possible biomarkers for AMD progression and this is the endpoint of
an ongoing prospective study.
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